Zepp Health Corporation
ZEPP
$2.71
-$0.02-0.73%
NYSE
| 09/30/2024 | 03/31/2024 | 12/31/2023 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 298.63M | 352.92M | 352.94M | 420.68M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 298.63M | 352.92M | 352.94M | 420.68M |
| Cost of Revenue | -- | 206.56M | 260.54M | 260.55M | 325.94M |
| Gross Profit | -- | 92.06M | 92.38M | 92.38M | 94.75M |
| SG&A Expenses | -- | 68.57M | 71.26M | 71.21M | 79.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 322.74M | 383.24M | 383.14M | 461.73M |
| Operating Income | -- | -24.11M | -30.33M | -30.21M | -41.05M |
| Income Before Tax | -- | -24.43M | -33.39M | -33.27M | -46.03M |
| Income Tax Expenses | -- | 1.26M | -2.43M | -2.43M | -5.56M |
| Earnings from Continuing Operations | -- | -25.68 | -30.96 | -30.85 | -40.47 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 70.40K | 66.60K | 66.20K | 108.80K |
| Net Income | -- | -25.61M | -30.90M | -30.78M | -40.36M |
| EBIT | -- | -24.11M | -30.33M | -30.21M | -41.05M |
| EBITDA | -- | -16.30M | -22.27M | -22.14M | -32.82M |
| EPS Basic | -- | -25.98 | -32.35 | -32.23 | -42.23 |
| Normalized Basic EPS | -- | -0.52 | -0.86 | -0.85 | -1.44 |
| EPS Diluted | -- | -26.16 | -32.49 | -32.39 | -42.42 |
| Normalized Diluted EPS | -- | -0.52 | -0.86 | -0.85 | -1.44 |
| Average Basic Shares Outstanding | -- | 61.73M | 60.84M | 60.84M | 61.04M |
| Average Diluted Shares Outstanding | -- | 3.91M | 3.85M | 3.85M | 3.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |